StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report released on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
The company has a market cap of $833,000.00, a PE ratio of -0.01 and a beta of -0.90. Athersys has a one year low of $0.01 and a one year high of $1.99.
About Athersys
Read More
- Five stocks we like better than Athersys
- Breakout Stocks: What They Are and How to Identify Them
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- How Can Investors Benefit From After-Hours Trading
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
